The subgroup analysis results showed that promoter methylation of PDZD11 was possibly affected by individual cancer stages, race, gender, age, weight, tumor grade, nodal metastasis status, and TP53 mutation status in LIHC (Figures 3C–J). This evidence concerns the gene TP53 and neoplasm.